SMAD4 and colorectal carcinoma: Our results indicate that SMAD4 likely plays a crucial role in activating NK cells to suppress CRC progression, and targeted activation of SMAD4 in human NK cells may represent a promising therapeutic approach for inhibiting CRC advancement.